Form D · Other Investment Fund
Thematic Select: PFM Therapeutics Ltd
New York, NY · CIK 0001758632
Offering snapshot reported Nov 14, 2019 · SEC filing
- Reported sold
- $4M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 30, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2019 | Amendment | $4,000,000 | $0vs Nov 14, 2018 | 1 | SEC filing |
| Nov 14, 2018 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325707
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Goldman Sachs & Co. LLC | 361 |
Source: Form D, filed Nov 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kent Clark | Director |
| Helen A. Crowley | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10282-2198
Phone: 212-902-1000